|
● |
Growth with higher returns: adjusted pre-tax profit up 6%, revenue up 2%, with adverse currency translation impact of 5% on revenue and profit. Return on Sales4 increased to 20.2%. |
|
● |
Organic constant currency revenue growth in all regions. Good performance in the USA; steady progress in the UK, Asia Pacific and Europe. |
|
● |
Strong profit growth maintained in Process Safety, Infrastructure Safety and Medical. Lower profit in Environmental & Analysis with improvement expected in the second half of the year. |
|
● |
£87m net cash spend on three acquisitions. Acquisition pipeline remains healthy. One disposal completed at a small gain. |
|
● |
Strong cash flow and significant financial capacity for investment in organic growth and value-adding acquisitions. Net debt of £136m (March 2014: £74m). |
|
● |
Interim dividend up 7% to 4.65p. |
|
● |
New Executive Board structure operating well, with an initial focus on sector growth strategies and development of management talent. |
